Literature DB >> 537273

Altered bile acid metabolism in alloxan diabetic rats.

K Uchida, H Takase, M Kadowaki, Y Nomura, T Matsubara, N Takeuchi.   

Abstract

Changes of cholesterol, phospholipid, triglyceride or bile acid levels in serum liver, bile and feces after the treatment with alloxan were examined in Wistar strain male rats. Serum cholesterol, phospholipid and triglyceride levels and liver cholesterol level markedly increased but liver phospholipid and triglyceride levels remained unchanged. The lipid levels in serum very low density and low density lipoproteins were elevated but those in high density lipoprotein were not. Bile flow was not changed but biliary secretion of cholesterol, phospholipid and bile acids markedly increased. Among the biliary bile acid components, cholic acid markedly increased but the amount of chenodeoxycholic acid was similar to that of normal rats. Fecal excretion of deoxycholic acid increased but that of lithocholic and hyodeoxycholic acids decreased, and alpha, beta- and omega-muricholic acids did not change, thus, the total amount of fecal bile acids remained unchanged. Hepatic cholesterol synthesis was markedly depressed, while cholesterol 7 alpha-hydroxylase activity did not change and cytochrome P-450 content was elevated by about 40%. From such evidence, it was apparent that synthesis of cholic acid increased while that of chenodeoxycholic acid decreased and the total amount of bile acids synthesized did not change in the diabetic rats. Furthermore, marked increase of the pool size of cholic acid and hepatic secretion of cholic acid stimulated the absorption of lipids and produced a hyperlipidemia in the diabetic rats.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 537273     DOI: 10.1254/jjp.29.553

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  10 in total

1.  Identification and characterization of cis-acting elements conferring insulin responsiveness on hamster cholesterol 7alpha-hydroxylase gene promoter.

Authors:  E De Fabiani; M Crestani; M Marrapodi; A Pinelli; V Golfieri; G Galli
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

2.  Plasma metabolomic profile in nonalcoholic fatty liver disease.

Authors:  Satish C Kalhan; Lining Guo; John Edmison; Srinivasan Dasarathy; Arthur J McCullough; Richard W Hanson; Mike Milburn
Journal:  Metabolism       Date:  2010-04-27       Impact factor: 8.694

3.  Type 1 diabetes is associated with an increase in cholesterol absorption markers but a decrease in cholesterol synthesis markers in a young adult population.

Authors:  Ivana Semova; Amy E Levenson; Joanna Krawczyk; Kevin Bullock; Kathryn A Williams; R Paul Wadwa; Amy S Shah; Philip R Khoury; Thomas R Kimball; Elaine M Urbina; Sarah D de Ferranti; Franziska K Bishop; David M Maahs; Lawrence M Dolan; Clary B Clish; Sudha B Biddinger
Journal:  J Clin Lipidol       Date:  2019-09-25       Impact factor: 4.766

4.  Type I diabetes mellitus decreases in vivo macrophage-to-feces reverse cholesterol transport despite increased biliary sterol secretion in mice.

Authors:  Jan Freark de Boer; Wijtske Annema; Marijke Schreurs; Jelske N van der Veen; Markus van der Giet; Niels Nijstad; Folkert Kuipers; Uwe J F Tietge
Journal:  J Lipid Res       Date:  2011-12-18       Impact factor: 5.922

5.  Insulin Prevents Hypercholesterolemia by Suppressing 12α-Hydroxylated Bile Acids.

Authors:  Ivana Semova; Amy E Levenson; Joanna Krawczyk; Kevin Bullock; Mary E Gearing; Alisha V Ling; Kathryn A Williams; Ji Miao; Stuart S Adamson; Dong-Ju Shin; Satyapal Chahar; Mark J Graham; Rosanne M Crooke; Lee R Hagey; David Vicent; Sarah D de Ferranti; Srividya Kidambi; Clary B Clish; Sudha B Biddinger
Journal:  Circulation       Date:  2022-02-23       Impact factor: 39.918

6.  Effects of diabetes on the expressed and total activities of 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver in vivo. Reversal by insulin treatment.

Authors:  R A Easom; V A Zammit
Journal:  Biochem J       Date:  1985-09-15       Impact factor: 3.857

7.  Increased biliary cholesterol secretion in alloxan diabetic mice.

Authors:  Y Ishikawa; K Uchida; T Akiyoshi
Journal:  Jpn J Surg       Date:  1984-03

8.  Hepatic insulin receptor deficiency impairs the SREBP-2 response to feeding and statins.

Authors:  Ji Miao; Joel T Haas; Praveen Manthena; Yanning Wang; Enpeng Zhao; Bhavapriya Vaitheesvaran; Irwin J Kurland; Sudha B Biddinger
Journal:  J Lipid Res       Date:  2014-02-10       Impact factor: 5.922

9.  Dysregulation of Δ4-3-oxosteroid 5β-reductase in diabetic patients: Implications and mechanisms.

Authors:  Leila Valanejad; Mwlod Ghareeb; Stephanie Shiffka; Christina Nadolny; Yuan Chen; Liangran Guo; Ruchi Verma; Sangmin You; Fatemeh Akhlaghi; Ruitang Deng
Journal:  Mol Cell Endocrinol       Date:  2017-10-09       Impact factor: 4.102

10.  Effect of Roux-en-Y gastric bypass surgery on bile acid metabolism in normal and obese diabetic rats.

Authors:  Hina Y Bhutta; Neetu Rajpal; Wendy White; Johannes M Freudenberg; Yaping Liu; James Way; Deepak Rajpal; David C Cooper; Andrew Young; Ali Tavakkoli; Lihong Chen
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.